The groundbreaking therapy of the medication represents a major development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – providing https://tirzepatidepeptide193692.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56734080